Русский медицинский журнал. Медицинское обозрение.
Общество с ограниченной ответственностью "Русский Медицинский Журнал".
Том 8.
2024.
С. 356-361
Optimization of therapy in secondary progressive multiple sclerosis; [Оптимизация терапии вторично-прогрессирующего рассеянного склероза]
The article provides an analysis of modern methods of treatment of secondary progressive multiple sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations and without exacerbations) is siponimod. Clinical trials of this drug have proven its efficacy and safety in this type of MS. If the drug is included in the list of high-cost technologies, this modern method of treating SPMS can be made available to all patients who need it. © 2024 Ima-Press Publishing House. All rights reserved.
Авторы
Boyko A.N. ,
Zyryanov S.K. ,
Vlasov Ya.V.
Издательство
Ima-Press Publishing House
Язык
Русский
Страницы
88-90
Статус
Опубликовано
Ссылка
Год
2024
Организации
- 1 N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, 1, Ostrovityanova St., Moscow, 117997, Russian Federation
- 2 Federal Center of Brain and Neurotechnologies, FMBA of Russia, 1, Ostrovityanova St., Build. 10, Moscow, 117997, Russian Federation
- 3 Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), 6, Miklukho-Maklaya St., Moscow, 117198, Russian Federation
- 4 City Clinical Hospital No. 24, Moscow City Healthcare Department, 10, Pistsovaya St., Moscow, 127015, Russian Federation
- 5 Samara State Medical University, Ministry of Health of Russia, 89, Chapaevskaya St., Samara, 443099, Russian Federation
Ключевые слова
multiple sclerosis; secondary progressive multiple sclerosis; siponimod; treatment
Поделиться
Другие записи
СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ.
Tomsk National Research Medical Center of the Russian Academy of Sciences.
Том 23.
2024.
С. 125-140